International Journal of
Reproductive Biomedicine
Sat, Apr 20, 2024
[Archive]
Volume 11, Issue 10 (12-2013)
IJRM 2013, 11(10): 785-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Aflatoonian A, Amouzegar H, Dehghani Firouzabadi R. Efficacy of 17α- hydroxy progestrone on decreasing preterm labor in ART pregnancies: A randomized clinical trial. IJRM 2013; 11 (10) :785-0
URL: http://ijrm.ir/article-1-356-en.html
URL: http://ijrm.ir/article-1-356-en.html
1- Department of Obstetrics and Gynecology, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Department of Obstetrics and Gynecology, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , amuzegarhoora@yahoo.com
2- Department of Obstetrics and Gynecology, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , amuzegarhoora@yahoo.com
Abstract: (4240 Views)
Background: Preterm labor (PTL) is one of the most important causes in neonatal mortality and morbidity. Late preterm labor (34-36w) includes 75% of such birth. Assisted reproductive technology (ART) pregnant women are at increased risk of PTL.
Objective: The study has been undertaken to determine whether beginning and continuing 17-α hydroxy progesterone caproate can reduce risk of PTL or change neonatal mortality.
Materials and Methods: In a double-blind clinical randomized control trial, 106 women were treated by ART technique for their infertility and in gestational age at 16 weeks entered in our study. In one group, 17-α hydroxy progesterone caproate (Femolife) was injected intramuscularly every week until 36 weeks of gestation and in another group; placebo was injected from 16 until 36 weeks of gestetion. Data collected from pregnancy outcomes, infancy, and subsidiary problems were statistically analyzed by a questionnaire.
Results: The risk of PTL in placebo group was 2.48 higher than control group that was not significant (Cl: 0.81-9.94). Femolife side effect in case group was gestational diabetes and local complication was not frequent. NICU admission was not significantly different between groups.
Conclusion: Although it seems that 17-α hydroxy progesterone caproate does not cause significantly decrease in PTL in singleton ART gestations but any reduction of PTL in such high risk pregnancies may improve final gestational outcome. There is critical need for larger clinical trials to better understanding causes of PTL, specifically late preterm labor, to prevent mortality and morbidity in ART gestation.
Objective: The study has been undertaken to determine whether beginning and continuing 17-α hydroxy progesterone caproate can reduce risk of PTL or change neonatal mortality.
Materials and Methods: In a double-blind clinical randomized control trial, 106 women were treated by ART technique for their infertility and in gestational age at 16 weeks entered in our study. In one group, 17-α hydroxy progesterone caproate (Femolife) was injected intramuscularly every week until 36 weeks of gestation and in another group; placebo was injected from 16 until 36 weeks of gestetion. Data collected from pregnancy outcomes, infancy, and subsidiary problems were statistically analyzed by a questionnaire.
Results: The risk of PTL in placebo group was 2.48 higher than control group that was not significant (Cl: 0.81-9.94). Femolife side effect in case group was gestational diabetes and local complication was not frequent. NICU admission was not significantly different between groups.
Conclusion: Although it seems that 17-α hydroxy progesterone caproate does not cause significantly decrease in PTL in singleton ART gestations but any reduction of PTL in such high risk pregnancies may improve final gestational outcome. There is critical need for larger clinical trials to better understanding causes of PTL, specifically late preterm labor, to prevent mortality and morbidity in ART gestation.
Keywords: Preterm labor, Assisted reproductive technology
Type of Study: Original Article |
References
1. World Health Organization (WHO). Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO October 14 1976. Acta Obstet Gynecol Scand 1977; 56: 247-253.
2. Villar J, Abalos E, Carroli G, Giordano D, Wojdyla D, Piaggio G, et al. Heterogeneity of perinatal outcomes in the preterm delivery syndrome. Obstet Gynecol 2004; 104: 78-87. [DOI:10.1097/01.AOG.0000130837.57743.7b]
3. Steer P. The epidemiology of preterm labour. BJOG 2005; 112 (Suppl.): 1-3. [DOI:10.1111/j.1471-0528.2005.00575.x]
4. Wen SW, Smith G, Yang Q, Walker M. Epidemiology of pretermbirth and neonatal outcome. Semin Fetal Neonatal Med 2004; 9: 429-435. [DOI:10.1016/j.siny.2004.04.002]
5. Laws PJ, Graylon N, Sullivan EA. Australia's mothers and babies 2004.Sydney: Australian Institute of Health and Welfare, National Perinatal Statistics Unit; 2006.
6. Blondel B, Macfarlane A, Gissler M, Breart G, Zeitlin J, Groupft PS. Preterm birth and multiple pregnancy in European countries participating in the PERISTAT project. BJOG 2006; 113: 528-535. [DOI:10.1111/j.1471-0528.2006.00923.x]
7. Gyamfi C, Horton AL, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, et al. The effect of 17-alpha hydroxyl-progesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies. Am J Obstet Gynecol 2009; 201: 392. [DOI:10.1016/j.ajog.2009.06.036]
8. Smith GC, Shah I, Pell JP, Crossley JA, Dobbie R. Maternal obesity inearly pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study. Am J Public Health 2007; 97: 157-162. [DOI:10.2105/AJPH.2005.074294]
9. Burguet A, Kaminski M, Abraham-Lerat L, Schaal JP, Cambonie G, Fresson J, et al. The complex relationship between smoking in pregnancy and very preterm delivery. Results of the Epipage study. BJOG 2004; 111: 258-265. [DOI:10.1046/j.1471-0528.2003.00037.x]
10. Williams Obstetrics. 23th Ed. Mc graw hill publication; 2010: 805-810.
11. Buck GM, Msall ME, Schisterman EF, Lyon NR, Rogers BT. Extreme prematurity and school outcomes. Paediatr Perinat Epidemiol 2000; 14: 324-331. [DOI:10.1046/j.1365-3016.2000.00276.x]
12. Berek and Novak's Gynecology. 15th Ed. Lippincott Williams and wilkins a wolters kluwer business, 2012:1206-1207.
13. Challis JR, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocrin Rev 2000; 21: 514-550. [DOI:10.1210/er.21.5.514]
14. Astle S, Slater DM, Thornton S. The involvement of progesterone in the onset of human labour. Eur J Obstet Gynecol Reprod Biol 2003; 108: 177-181. [DOI:10.1016/S0301-2115(02)00422-0]
15. Levine L. Habitual abortion. A controlled clinical study of progestational therapy. West J Surg Obstet Gynecol 1964; 72: 30-36.
16. Dodd JM, Crowther CA. The role of progesterone in prevention of preterm birth. Int J Womens Health 2010; 1: 73-84.
17. Wisborg K, Ingerslev HJ, Henriksen TB. In vitro fertilization and preterm delivery, low birth weight, and admission to the neonatal intensive care unit: a prospective follow-up study. Fertil Steril 2010; 94: 2102-2106. [DOI:10.1016/j.fertnstert.2010.01.014]
18. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. National Institute of Child Health and Human Development Maternal- Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17α-hydroxy progesterone caproate. N Engl J Med 2003; 348: 2379-2385. [DOI:10.1056/NEJMoa035140]
19. Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2006; 194: 1234-1242. [DOI:10.1016/j.ajog.2005.06.049]
20. Stokes TA, Holston A, Olsen C, Choi Y, Curtis J, Higginson J, et al. Preterm Infants of Lower Gestational Age at Birth Have Greater Waist Circumference-Length Ratio and Ponderal Index at Term Age than Preterm Infants of Higher Gestational Ages. J Pediatr 2012; 161: 735-741. [DOI:10.1016/j.jpeds.2012.03.023]
21. Bahadori F, Borna S, Shakouienejad S, Sahabi N. [Progesterone and the latency period: threatened preterm labor]. Tehran Univ Med J 2008; 66: 237-241. (In Persian)
22. Lucas B, Poole-Yaeger A, Istwan N, Stanziano G, Rhea D, Mason M. Pregnancy Outcomes of Managed Medicaid Members Prescribed Home Administration of 17α-Hydroxy progesterone Caproate. Am J Perinatol 2012; 29: 489-496.
23. Wisborg K, Ingersleve HJ, Brink Henrikson T. IVF and pereterm delivery, Low birth Weigh and admission to the neonatal ICU Caprospectno follow upoy. Fertil Steril 2010; 94: 2102-2106. [DOI:10.1016/j.fertnstert.2010.01.014]
24. Mason MV, Poole-Yaeger A, Krueger CR, House KM, Lucas B. Impact of usage of NICU admission in a managed medicaid population-afive-year review. Manag care 2010; 19: 46-52.
25. Waters TP, Schultz BA, Mercer BM, Catalano PM. Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy. Obstet Gynecol 2009; 114: 45-49. [DOI:10.1097/AOG.0b013e3181a9454b]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
